Also, the administration of CMG017, another dual inhibitor of IDO and TDO, to tumor-bearing mice resulted in reduced kynurenine concentration, differential expression of immune-related genes and the infiltration of effector CD8+ T cells in the TME (87). This evidence concerns the gene TDO2 and neoplasm.